Yuen-chin Ong
Linkou, TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
β2-microglobulin is superior to lactate dehydrogenase and bulky disease for risk stratification in diffuse large B-cell lymphoma patients with IPI 1-2.
Journal: Annals of hematology
Published: March 30, 2026
Novel therapeutic agents and intensive chemotherapy improve survival outcomes in patients with mantle cell lymphoma.
Journal: American journal of cancer research
Published: October 22, 2025
Risk factors and clinical consequences of rituximab infusion-related reactions.
Journal: Medicine
Published: June 30, 2025
Different patterns of failure in two treatment regimens for primary central nervous system lymphoma, a retrospective analysis of 124 cases in Taiwan.
Journal: Clinical and experimental medicine
Published: June 18, 2023
Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma.
Journal: Clinical and experimental medicine
Published: November 15, 2022
Impact of Platelet Counts, Surgical Methods, and Preoperative Platelet Transfusion on the Outcome of Splenectomy for Immune Thrombocytopenia.
Journal: Acta haematologica
Published: August 13, 2019
Intravascular Large B-cell lymphoma: A case series and review of literatures.
Journal: Biomedical journal
Published: May 16, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026